Andrés Ponce, Beatriz Frade-Sosa, Juan C Sarmiento-Monroy, Nuria Sapena, Julio Ramírez, Ana Belén Azuaga, Rosa Morlà, Virginia Ruiz-Esquide, Juan D Cañete, Raimon Sanmartí, José A Gómez-Puerta
Immune checkpoint inhibitor (ICI)-induced arthritis is an increasingly recognized adverse event in patients with oncologic disease during immunotherapy. Four patterns are well described, including rheumatoid arthritis (RA)-like, polymyalgia rheumatica (PMR)-like, psoriatic arthritis (PsA)-like, and oligo-monoarthritis, among others. Despite better clinical recognition of these syndromes, information about the main imaging findings is limited. METHODS: We conducted a retrospective observational study including all adult patients referred to the Rheumatology Department of a single-center due to ICI-induced arthritis who underwent imaging studies [ultrasound (US), magnetic resonance imaging (MRI), and 18 F-FDG PET/CT)] between January 2017 and January 2022...
August 13, 2022: Diagnostics